New York State Common Retirement Fund
CLYM

New York State Common Retirement Fund’s Climb Bio CLYM Stock Holding History

New York State Common Retirement Fund’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,500
Closed -$12.8K – 3374
2025
Q1 		$12.8K Hold
10,500
– – ﹤0.01% 3048
2024
Q4 		$18.9K Hold
10,500
– – ﹤0.01% 3046
2024
Q3 		$53.4K Sell
10,500
-2,800
-21% -$19.8K ﹤0.01% 2841
2024
Q2 		$94.6K Buy
+13,300
New +$88.5K ﹤0.01% 2891
2022
Q3 		– Sell
-59
Closed – – 3477
2022
Q2 		$0 Sell
59
-3,300
-98% -$15.6K ﹤0.01% 3551
2022
Q1 		$28K Hold
3,359
– – ﹤0.01% 3260
2021
Q4 		$35K Buy
+3,359
New +$50.1K ﹤0.01% 3269

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

New York State Common Retirement Fund's CLYM Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Climb Bio (CLYM) in Q2 2025, closing a stake of 10,500 shares — an estimated $12.8K sold.

New York State Common Retirement Fund first reported a position in CLYM in Q4 2021 and held it in 7 quarters. The position peaked at $94.6K in Q2 2024. 69 funds tracked by Wall St. Rank hold CLYM as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Climb Bio position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 10,500 Climb Bio shares in Q2 2025, an estimated $12.8K.
  • New York State Common Retirement Fund first reported a position in Climb Bio in Q4 2021 and held it in 7 quarters.
  • New York State Common Retirement Fund's Climb Bio position peaked at $94.6K in Q2 2024.
  • 69 funds tracked by Wall St. Rank held Climb Bio as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.